Etiopathogenesis of arrhythmogenic right ventricular cardiomyopathy.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterised by progressive fibro-fatty replacement of right ventricular myocardium. Earlier studies described ARVC as non-inflammatory, non-coronary disorder associated with arrhythmias, heart failure and sudden death due to functional exclusion of the right ventricle. Molecular genetic studies have identified nine different loci associated with ARVC; accordingly each locus is implicated for each type of ARVC (ARVC1-ARVC9). So far five genes have been identified as containing pathogenic mutations for ARVC. Though mutations in each of the gene/s indicate disruption of different pathways leading to the condition, the exact pathogenesis of the condition is still obscure. This review tries to understand the pathogenesis of the condition by examining the individual proteins implicated and relate them to the pathways that could play a role in the aetiology of the condition. Cardiac ryanodine receptor (RYR-2), which regulates intra-cellular Ca(2+) concentration by releasing Ca(2+) reserves from the sarcoplasmic reticulum (SR), was the first gene for ARVC. The mutation in this gene is believed to disrupt coupled gating of RYR-2, causing after-depolarisation, leading to arrhythmias followed by structural changes due to altered intra-cellular Ca(2+) levels. Three other genes implicated for ARVC, plakoglobin (Naxos disease), desmoplakin (ARVC8) and plakophilin (ARVC9) have prompted the speculation that ARVC is primarily a disease of desmosomes. But identification of TGFbeta-3 for ARVC1 and the role of all these three genes (plakoglobin, desmoplakin and plakophilin) in cardiac morphogenesis indicate some kind of signal-transducing pathway disruption in the condition. The finding that ARVC as a milder form of Uhl's anomaly indicates similar ontogeny for the condition. Further, discovery of apoptotic cells in the autopsy of the right ventricular myocardium of ARVC patients does indicate a common pathway for different types of ARVCs, which is more specific for the right ventricular myocardium involving desmosomal plaque proteins, growth factors and Ca(2+) receptors.
Dokuparti
Maithili V N
MVN
Department of Genetics, University College of Science, Osmania University, Jamia Osmania Post Office, Hyderabad, 500 007, Andhra Pradesh, India.
Pamuru
Pranathi Rao
PR
Department of Genetics, University College of Science, Osmania University, Jamia Osmania Post Office, Hyderabad, 500 007, Andhra Pradesh, India.
Thakkar
Bhavesh
B
Department of Genetics, University College of Science, Osmania University, Jamia Osmania Post Office, Hyderabad, 500 007, Andhra Pradesh, India.|King Edward Memorial Hospital, Parel, Mumbai, India.
Tanjore
Reena R
RR
Department of Genetics, University College of Science, Osmania University, Jamia Osmania Post Office, Hyderabad, 500 007, Andhra Pradesh, India.
Nallari
Pratibha
P
Department of Genetics, University College of Science, Osmania University, Jamia Osmania Post Office, Hyderabad, 500 007, Andhra Pradesh, India. prathinallari@yahoo.com.
D019571:Arrhythmogenic Right Ventricular Dysplasia / Q000209:etiology* / Q000235:genetics / Q000473:pathology; D016757:Death, Sudden, Cardiac / Q000209:etiology; D003896:Desmosomes / Q000235:genetics / Q000473:pathology; D006801:Humans; D008954:Models, Biological; D009154:Mutation; D019837:Ryanodine Receptor Calcium Release Channel / Q000235:genetics
D019837:Ryanodine Receptor Calcium Release Channel